Correlates of thrombin markers in an elderly cohort free of clinical cardiovascular disease.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Arteriosclerosis, Thrombosis and Vascular Biology

• Publication date

  1996-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.ATV.16.9.1163PMID 8792770
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association of Fibrinogen and Coagulation Factors Vll and VIII with Cardiovascular Risk Factors in the Elderly The Cardiovascular Health Study

  1996cited by this paper
• Association of fibrinogen and coagulation factors VII and VIII with cardiovascular risk factors in the elderly: the Cardiovascular Health Study. Cardiovascular Health Study Investigators.

  1996cited by this paper
• Methods of assessing prevalent cardiovascular disease in the Cardiovascular Health Study.

  1995cited by this paper
• Laboratory methods and quality assurance in the Cardiovascular Health Study.

  1995cited by this paper
• The Effects of Quality and Timing of Venepuncture on Markers of Blood Coagulation in Healthy Middle-aged Men

  1995cited by this paper
• Evaluation of preanalytical variables associated with measurement of prothrombin fragment 1.2.

  1994cited by this paper
• Fibrinogen Plasma Levels as a Marker of Thrombin Activation: New Insights on the Role of Fibrinogen as a Cardiovascular Risk Factor

  1994cited by this paper
• Apolipoprotein(a), Fibrinopeptide A and Carotid Atherosclerosis in Middle-Aged Men

  1994cited by this paper
• Fibrinogen and factor VII in the prediction of coronary risk. Results from the PROCAM study in healthy men.

  1994cited by this paper
• The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina.

  1994cited by this paper
• Endogenous tissue-type plasminogen activator and risk of myocardial infarction.

  1993cited by this paper
• Atherogenesis and inflammation.

  1993cited by this paper
• Effects of age, race, sex, and smoking on prothrombin fragment 1.2 in a healthy population.

  1993cited by this paper
• Recruitment of adults 65 years and older as participants in the Cardiovascular Health Study.

  1993cited by this paper
• Lipoprotein(a) and its role in occlusive vascular disease.

  1993cited by this paper
• Ankle-arm index as a marker of atherosclerosis in the Cardiovascular Health Study. Cardiovascular Heart Study (CHS) Collaborative Research Group.

  1993cited by this paper
• Coagulation system activation and increase of D‐dimer levels in peripheral arterial occlusive disease

  1993cited by this paper
• Thrombosis and cardiovascular risk in the elderly.

  1992cited by this paper
• The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group.

  1992cited by this paper
• Echocardiographic design of a multicenter investigation of free-living elderly subjects: the Cardiovascular Health Study.

  1992cited by this paper
• Gemfibrozil Reduces Plasma Prothrombin Fragment F1+2 Concentration, a Marker of Coagulability, in Patients with Coronary Heart Disease

  1992cited by this paper
• Fibrinogen, a cardiovascular risk factor

  1992cited by this paper
• The distribution of coagulation factors VII and VIII and fibrinogen in adults over 65 years. Results from the Cardiovascular Health Study.

  1992cited by this paper
• The pathogenesis of coronary artery disease and the acute coronary syndromes (2).

  1992cited by this paper
• The pathogenesis of coronary artery disease and the acute coronary syndromes (1).

  1992cited by this paper
• Prothrombin fragment F1 + 2 and thrombin-antithrombin III complex are useful markers of the hypercoagulable state in atrial fibrillation.

  1992cited by this paper
• Influence of aging on the activity of the hemostatic system: prothrombin fragment 1+2, thrombin-antithrombin III complexes and D-dimers in 80 healthy subjects with age ranging from 20 to 94 years.

  1992cited by this paper
• Major electrocardiographic abnormalities in persons aged 65 years and older (the Cardiovascular Health Study). Cardiovascular Health Study Collaborative Research Group.

  1992cited by this paper
• Modern management of acute myocardial infarction in the community hospital: Edited by Jeffrey L. Anderson. New York, NY, Marcel Dekker, 1991, 560 pp, $89.75

  1992cited by this paper
• Use of sonography to evaluate carotid atherosclerosis in the elderly. The Cardiovascular Health Study. CHS Collaborative Research Group.

  1991cited by this paper
• Determination of Human Prothrombin Activation Fragment 1+2 in Plasma with an Antibody against a Synthetic Peptide

  1991cited by this paper
• Fibrinogen, Viscosity, and White Blood Cell Count Are Major Risk Factors for Ischemic Heart Disease: The Caerphilly and Speedwell Collaborative Heart Disease Studies

  1991cited by this paper
• The Cardiovascular Health Study: design and rationale.

  1991cited by this paper
• Are there markers of the blood-vessel wall interaction and of thrombus formation that can be used clinically?

  1990cited by this paper
• Atherosclerotic plaque rupture and thrombosis. Evolving concepts.

  1990cited by this paper
• A monoclonal-antibody-based enzyme-linked immunosorbent assay of lipoprotein(a).

  1990cited by this paper
• Fibrinopeptide A levels in patients with acute ischaemic heart disease.

  1989cited by this paper
• Impaired Fibrinolytic Capacity and Tissue Plasminogen Activator Release in Patients with Restenosis after Percutaneous Transluminal Coronary Angioplasty (PTCA)

  1989cited by this paper
• The Utility of Plasma Fibrinopeptide Assays

  1989cited by this paper
• Fibrinopeptide A and platelet factor levels in unstable angina pectoris.

  1987cited by this paper
• Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction.

  1987cited by this paper
• Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative Aging Study.

  1987cited by this paper
• Fibrinogen and risk of cardiovascular disease. The Framingham Study.

  1987cited by this paper
• Fibrinolytic Response and Fibrin Fragment D-Dimer Levels in Patients with Deep Vein Thrombosis

  1987cited by this paper
• Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study.

  1986cited by this paper
• Fibrinopeptide A: a marker of acute coronary thrombosis.

  1985cited by this paper
• Acute Coronary Care

  1985cited by this paper
• Markers of Fibrinogen Derivatives Used in Clinical Investigation

  1985cited by this paper
• Fibrinogen as a risk factor for stroke and myocardial infarction.

  1984cited by this paper
• Rapid radioimmunoassay of human fibrinopeptide A - removal of cross-reacting fibrinogen with bentonite.

  1980cited by this paper
• Plasma fibrinopeptide A levels in symptomatic venous thromboembolism.

  1978cited by this paper
• Measurement of fibrinopeptide A in human blood.

  1974cited by this paper
• The Electrocardiogram in Population Studies: A Classification System

  1960cited by this paper

• Metabolomic Biomarkers of Rest-Activity Rhythms in Older Women: Results from the Women's Health Initiative (WHI) Study.

  2025cites this paper
• Highly sensitive and label-free protein immunoassay-based biosensor comprising infrared metamaterial absorber inducing strong coupling.

  2024cites this paper
• Emerging Novel Diagnostic Measure: Prothrombin Fragment 1+2

  2023cites this paper
• DNase 1 Protects From Increased Thrombin Generation and Venous Thrombosis During Aging: Cross‐Sectional Study in Mice and Humans

  2022cites this paper
• CHA2DS2-VASc score stratifies mortality risk in heart failure patients aged 75 years and older with and without atrial fibrillation

  2022cites this paper
• Hemostatic factor levels and cognitive decline in older adults: The Cardiovascular Health Study

  2021cites this paper
• Paroxysmal Atrial Fibrillation: An Independent Risk Factor for Prothrombotic Conditions.

  2020cites this paper
• Coagulation Changes in Children with Sickle Cell Anaemia during Painful Crises and Steady State at Federal Medical Centre Abeokuta, Nigeria

  2018cites this paper
• ChA 2 Ds 2 -VAsc score as a predictor of long-term cardiac outcomes in elderly patients with or without atrial fibrillation

  2018cites this paper
• CHA2DS2-VASc score as a predictor of long-term cardiac outcomes in elderly patients with or without atrial fibrillation

  2018cites this paper
• Biological Processes and Biomarkers Related to Frailty in Older Adults: A State-of-the-Science Literature Review

  2018cites this paper
• Stroke and death prediction with CHA2DS2-vasc score after myocardial infarction in patients without atrial fibrillation

  2015cites this paper
• Platelet function recovery following exposure to triple anti-platelet inhibitors using an in vitro transfusion model.

  2015cites this paper
• The spectrum of thrombin in acute coronary syndromes.

  2015cites this paper
• The effect of VKORC1 (-1639 G>A) gene polymorphism and its related clotting factor IIa and Xa on warfarin therapy in patients with atrial fibrillation: a multi-ethnic Sarawak population study

  2015influential citation
• Thrombin and FXa plasma concentration levels in patients with atrial fibrillation on long term warfarin therapy

  2014cites this paper
• The association between fibrinolysis markers and body composition in black adults in the North West Province of South Africa

  2014cites this paper
• Incorporating biomarkers into cancer and aging research.

  2014cites this paper
• Mechanisms of cardiovascular disease in the metabolic syndrome and type 2 diabetes mellitus : focus on adverse intermediate phenotypes

  2013cites this paper
• Persistent subclinical hypothyroidism and cardiovascular risk in the elderly: the cardiovascular health study.

  2013cites this paper
• Atrial Fibrillation: Current and Forthcoming Antithrombotic Therapies

  2012cites this paper
• AF and Venous Thromboembolism - Pathophysiology, Risk Assessment and CHADS-VASc score.

  2012cites this paper
• Elevation of serum high molecular weight adiponectin in patients with Type 2 diabetes and orthostatic hypotension: association with arterial stiffness and hypercoagulability

  2012cites this paper
• 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.

  2011cites this paper
• Developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society

  2011cites this paper
• 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the Europe

  2011cites this paper
• Prothrombin fragments in cardiovascular disease.

  2010cites this paper
• The Hoorn Study

  2010cites this paper
• Is thrombin a key player in the 'coagulation-atherogenesis' maze?

  2009cites this paper
• Procarboxypeptidase U (TAFI) contributes to the risk of thrombosis in patients with hereditary thrombophilia.

  2009cites this paper
• Peak thrombin generation and subsequent venous thromboembolism: the Longitudinal Investigation of Thromboembolism Etiology (LITE) study

  2009cites this paper
• Risk factors, atrial fibrillation and thromboembolic events.

  2008cites this paper
• Effect of progestogen and progestogen type on hemostasis measures in postmenopausal women: the Postmenopausal Estrogen/Progestin Intervention (PEPI) Study

  2008cites this paper
• Inflammation and haemostasis in the development and progression of peripheral atherosclerotic disease

  2007cites this paper
• Relationship of waist and hip circumference with coagulation and fibrinolysis in postmenopausal women.

  2007cites this paper
• Effect of the novel direct factor Xa inhibitor DX-9065a on thrombin generation and inhibition among patients with stable atherosclerotic coronary artery disease.

  2006cites this paper
• ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Commit

  2006cites this paper
• Atherothrombosis and the Metabolic Syndrome

  2006cites this paper
• Relation of the prothrombotic state to increasing age (from the Framingham Offspring Study).

  2005cites this paper
• No effect of folic acid supplementation in the course of 1 year on haemostasis markers and C-reactive protein in older adults

  2005cites this paper
• Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly.

  2005cites this paper
• Prothrombin Fragment 1+2 Is Associated With Carotid Intima-Media Thickness in Subjects Free of Clinical Cardiovascular Disease

  2004cites this paper
• Inhibition of Platelet Aggregation with a Glycoprotein IIb-IIIa Antagonist Does Not Prevent Thrombin Generation in Patients Undergoing Thrombolysis for Acute Myocardial Infarction

  2004cites this paper
• Changes in Thrombelastograph™ Variables Associated with Aging

  2004cites this paper
• Low‐intensity warfarin reduces thrombin generation and fibrin turnover, but not low‐grade inflammation, in men at risk of myocardial infarction

  2004cites this paper
• Onset of force development as a marker of thrombin generation in whole blood: the thrombin generation time (TGT)

  2003cites this paper
• Correlates of thrombin generation in patients with advanced prostate cancer

  2003cites this paper
• Coagulation and activation of inflammatory pathways in the development of functional decline and mortality in the elderly.

  2003cites this paper
• Hemostatic and inflammatory markers as risk factors for coronary disease in the elderly.

  2002cites this paper
• Aging and Thrombosis

  2002cites this paper
• No Association of Plasma Prothrombin Concentration or the G20210A Mutation with Incident Cardiovascular Disease

  2002influential citation
• Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study.

  2002cites this paper
• Effect of Homocysteine Reduction by B-Vitamin Supplementation on Markers of Clotting Activation

  2002cites this paper
• Tamoxifen and Cardiac Risk Factors in Healthy Women: Suggestion of an Anti-inflammatory Effect

  2001cites this paper
• Tamoxifen and Cardiac Risk Factors in Healthy Women Suggestion of an Anti-inflammatory Effect

  2001cites this paper
• ESC COMMITTEE FOR PRACTICE GUIDELINES & POLICY CONFERENCES MEMBERS

  2001cites this paper
• ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conference

  2001cites this paper
• Activation Products of the Haemostatic System in Coronary, Cerebrovascular and Peripheral Arterial Disease

  2001cites this paper
• Age-dependency in molecular markers of haemostasis, fibrinolysis and in soluble adhesion molecules

  2000cites this paper
• Clustering of procoagulation, inflammation, and fibrinolysis variables with metabolic factors in insulin resistance syndrome.

  2000cites this paper
• Haemostatic and Lipid Determinants of Prothrombin Fragment F1.2 and D-dimer in Plasma

  2000influential citation
• Age, functional status, and racial differences in plasma D-dimer levels in community-dwelling elderly persons.

  2000cites this paper
• Study of cardiovascular risk factors and hemostatic molecular markers in elderly persons.

  2000cites this paper
• Plasmin-alpha2-antiplasmin complex in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators.

  1999cites this paper
• Emerging noninvasive biochemical measures to predict cardiovascular risk.

  1999cites this paper
• The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the cardiovascular health study.

  1999cites this paper
• Epidemiological Evidence for Inflammation in Cardiovascular Disease

  1999cites this paper
• Inflammation markers and coronary heart disease.

  1999cites this paper
• Haemostatic parameters related to lipids and adhesion molecules.

  1999cites this paper
• Atrial Fibrillation and Thromboembolism: A Decade of Progress in Stroke Prevention

  1999cites this paper
• AGING AND CARDIOVASCULAR DISEASE: Use of Subclinical Measurements

  1999cites this paper
• Plasmin-α2-antiplasmin Complex in Patients with Atrial Fibrillation

  1999cites this paper
• Relationship of plasmin generation to cardiovascular disease risk factors in elderly men and women.

  1999cites this paper
• Markers of thrombin and platelet activity in patients with atrial fibrillation: correlation with stroke among 1531 participants in the stroke prevention in atrial fibrillation III study.

  1999cites this paper
• Hormone replacement therapy, inflammation, and hemostasis in elderly women.

  1999cites this paper
• Correlates of Antithrombin, Protein C, Protein S, and TFPI in a Healthy Elderly Cohort

  1998influential citation
• Cardiopulmonary Bypass Pumps and Thrombin Generation: What Goes Around Comes Around

  1998cites this paper
• Activation of the Coagulant Pathway in Cigarette Smokers

  1998cites this paper
• Plasma Coagulation Factors

  1997cites this paper
• Hemostatic risk factors in arterial thrombosis and atherosclerosis: the thrombin-fibrin and platelet-vWF axis.

  1997cites this paper
• Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects.

  1997cites this paper
• Relationship between prothrombin activation fragment F1.2 and international normalized ratio in patients with atrial fibrillation. Stroke Prevention in Atrial Fibrillation Investigators.

  1997cites this paper